Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: melphalan

March 3, 2021 Drug delivery / Pharma applications

Improving Bioavailability & Solubility

Drug Development & delivery published on the virtual 2020 Global Drug Bioavailability Enhancement Summit, which this past December showcased novel

Continue reading

February 9, 2021 Drug delivery / Pharma applications

Successful use of SBECD as vehicle in intravitreal treatment

A retrospective study based on data collected from Memorial Sloan-Kettering Cancer Center, New York shows high efficacy and low toxicity

Continue reading

September 27, 2019 Drug delivery / Pharma applications

Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China

SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on

Continue reading

December 29, 2018 Drug delivery / Pharma applications

CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®)

National Medical Products Administration Approves Melphalan Hydrochloride For Injection (EVOMELA®, formulation based on SBECD aka. Captisol or Dexolve) as Treatment

Continue reading

Recent Posts

  • Crystallization inhibition by methylated cyclodextrin
  • Alfa-cyclodextrin MS-signals from Danish Golden Age paintings
  • The mechanism and therapy of aortic aneurysms
  • Pharmacokinetic studies of hyperoside-2-hydroxypropyl-β-cyclodextrin inclusion complex and ameliorated colitis in mice
  • A review on Sulfobutylether-β-cyclodextrin for drug delivery applications

Tags

alpha-CD Alzheimer disease Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (15)
  • Analysis (37)
  • CD as API (215)
  • CD derivatives (269)
  • Cosmetics and toilettry (22)
  • Diagnosis (1)
  • Drug delivery (461)
  • E-ducation (56)
  • Environmental (80)
  • Events (163)
  • Food (128)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (19)
  • Non-pharma applications (229)
  • Other industrial use (69)
  • Pharma applications (731)
  • Supramolecular systems (27)
  • Uncategorized (47)

Top Posts

  • The mechanism and therapy of aortic aneurysms
  • Lanosterol eye drops for cataract treatment
  • Crystallization inhibition by methylated cyclodextrin
  • Website of EuroCD Conference is open
  • How air fresheners work?
  • Alfa-cyclodextrin MS-signals from Danish Golden Age paintings
  • 7th European Cyclodextrin Conference
  • Health Canada’s Proposal to Enable the Use of alpha-Cyclodextrin as an Emulsifying, Stabilizing or Thickening Agent in Various Foods
  • Green materials with promising applications: Cyclodextrins-based deep eutectic supramolecular polymers
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 552 other subscribers
 

Loading Comments...